Last reviewed · How we verify
Hemophilia A or B
Approved treatments
Pipeline
- Marstacimab · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hemophilia A or B patent landscape — cliff calendar, originator estates, attackable patents
- Hemophilia A or B treatment landscape brief
- Hemophilia A or B treatment updates RSS
Frequently asked questions about Hemophilia A or B
What new drugs are in development for Hemophilia A or B?
1 pipeline drugs tracked. Top candidates: Marstacimab.
Related
- Treatment landscape: Hemophilia A or B patent cliff · Hemophilia A or B CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing